Skip to main content

GOLDMAN SACHS GROUP INC

Position in NGNE — Neurogene Inc.

CIK 886982 NEW YORK, NY

Position in NGNE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,185,129
+$1,013,616 QoQ
Shares Held
101,276
-6.0% QoQ
Ownership
0.506%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 111 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NGNE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. NGNE ranks #212 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NGNE

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,185,129 101,276
2026-03-31 $2,171,513 107,714
2025-12-31 $3,337,570 162,018
2025-09-30 $1,261,657 72,802
2025-06-30 $258,575 17,296
2025-03-31 $247,970 21,176
2024-12-31 $870,005 38,058
2024-09-30 $1,727,283 41,165
2024-06-30 $475,071 13,055
2024-03-31 $3,771,028 74,087